Keybank National Association OH Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Keybank National Association OH reduced its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 26.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,447 shares of the company’s stock after selling 3,763 shares during the quarter. Keybank National Association OH’s holdings in Prestige Consumer Healthcare were worth $816,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kestra Investment Management LLC purchased a new stake in Prestige Consumer Healthcare in the 4th quarter worth about $27,000. Huntington National Bank raised its position in Prestige Consumer Healthcare by 39.9% in the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after purchasing an additional 181 shares during the period. Covestor Ltd grew its stake in Prestige Consumer Healthcare by 95.6% in the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after acquiring an additional 654 shares in the last quarter. GAMMA Investing LLC grew its stake in Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares in the last quarter. Finally, KBC Group NV grew its stake in Prestige Consumer Healthcare by 28.3% in the 4th quarter. KBC Group NV now owns 2,048 shares of the company’s stock worth $160,000 after acquiring an additional 452 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

NYSE PBH opened at $89.10 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm’s 50 day moving average price is $80.80 and its 200-day moving average price is $77.83. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $89.65. The company has a market cap of $4.41 billion, a PE ratio of 20.87, a P/E/G ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on PBH shares. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a research note on Monday, December 9th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Oppenheimer upped their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Finally, DA Davidson upped their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.